Trajan Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.3M Buy
106,831
+4,135
+4% +$1.53M 1.56% 18
2026
Q1
$30.1M Buy
102,696
+10,459
+11% +$3.44M 1.21% 21
2025
Q4
$32.3M Buy
92,237
+5,966
+7% +$2.02M 1.35% 20
2025
Q3
$27.9M Buy
86,271
+12,846
+17% +$4M 1.2% 22
2025
Q2
$28.6M Buy
73,425
+8,644
+13% +$3.48M 1.4% 18
2025
Q1
$28.2M Buy
64,781
+12,400
+24% +$4.98M 1.54% 16
2024
Q4
$19.3M Buy
52,381
+2,839
+6% +$1.19M 1.07% 25
2024
Q3
$25.8M Buy
49,542
+15,025
+44% +$8.03M 1.52% 15
2024
Q2
$18.7M Buy
34,517
+2,338
+7% +$1.24M 1.2% 21
2024
Q1
$16.7M Buy
+32,179
New +$16M 1.13% 25

Other funds holding ELV

Trajan Wealth's ELV Position: Q2 2026 in Review

Trajan Wealth increased its Elevance Health (ELV) stake by 4% in Q2 2026, buying an estimated $1.53M and bringing the position to 106,831 shares worth $41.3M. The position accounts for 1.56% of the portfolio, ranked #18.

Trajan Wealth first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Trajan Wealth held 106,831 shares of Elevance Health worth $41.3M as of Q2 2026.
  • Trajan Wealth bought 4,135 Elevance Health shares in Q2 2026, an estimated $1.53M.
  • Elevance Health made up 1.56% of Trajan Wealth's portfolio in Q2 2026, its #18 holding.
  • Trajan Wealth first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Trajan Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.